Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CHMP1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PHTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBPF26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM126B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF2BP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF19A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC7A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUPT16H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
POLR2E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDIA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPCR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on